Journal article Open Access

FORMULATION AND EVALUATION OF SOLID LIPID NANOPARTICLES OF ETORICOXIB BY EMPLOYING GLYCERYL MONOSTEARATE AND GELUCIRE 48/16

Swetha Rani Balka, Dr. P.Tripura sundari*


MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Etoricoxib, Glycerylmonostearate, Soya Lecithin, Gelucire And Hot Homogenization Method.</subfield>
  </datafield>
  <controlfield tag="005">20190410032620.0</controlfield>
  <controlfield tag="001">2583502</controlfield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">964658</subfield>
    <subfield code="z">md5:590fe803a53d5214df408b4f1556765b</subfield>
    <subfield code="u">https://zenodo.org/record/2583502/files/181205.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2019-03-05</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="p">user-iajpr</subfield>
    <subfield code="o">oai:zenodo.org:2583502</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">RBVRR Women's College of Pharmacy, Osmania University, Barkatpura, Hyderabad, India.</subfield>
    <subfield code="a">Swetha Rani Balka, Dr. P.Tripura sundari*</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">FORMULATION AND EVALUATION OF SOLID LIPID NANOPARTICLES OF ETORICOXIB BY EMPLOYING GLYCERYL MONOSTEARATE AND GELUCIRE 48/16</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-iajpr</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">http://creativecommons.org/licenses/by/4.0/legalcode</subfield>
    <subfield code="a">Creative Commons Attribution 4.0 International</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;The aim of the present study is to formulate and evaluate solid lipid nanoparticles of Etoricoxib. Etoricoxib is a selective COX-2 inhibitor, these are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cycloxygenase-2, COX-2, an enzyme responsible for inflammation and pain. Etoricoxib is a poorly soluble drug. To overcome this problem an attempt was made to prepare Etoricoxib solid lipid nanoparticles which has ability to improve the solubility and enhance oral bioavailability. In the present study Etoricoxib loaded SLNs were prepared by Hot homogenization method. Different formulations of Solid lipid nanoparticles of Etoricoxib were prepared by employing Glyceryl Monostearate as a solid lipid, Soya lecithin as lipophilic surfactant and Gelucire 48/16 as hydrophilic surfactant. The evaluation studies like drug content, entrapment efficiency and drug release studies, Particle size analysis, zeta potential, were performed on the prepared formulations. Among all the prepared formulations E2 formulation was found to show better results.&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.5281/zenodo.2583501</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.5281/zenodo.2583502</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
</record>
17
7
views
downloads
All versions This version
Views 1717
Downloads 77
Data volume 6.8 MB6.8 MB
Unique views 1717
Unique downloads 77

Share

Cite as